A report by QuintilesIMS has found that despite a decline in spending growth, the global medicines spending will nearly reach $1.5 trillion by 2021.
The report also shares a few more key findings:
- speciality medicines will continue to rise
- increasing numbers of new medicines reaching patients (an average of 45 new active substances to be launched each year)
- biologic and biosimilar medicines will contribute to substantial savings